STOCK TITAN

DENTSPLY SIRONA (NASDAQ: XRAY) director logs RSU, option grants and family gifts

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Gregory T. Lucier reported a mix of equity awards and family wealth transfers in company stock. He made bona fide gifts of 38,382 shares of Common Stock and 10,900 stock options to a family partnership associated with a trust benefiting him, with his spouse as general partner.

At the same time, he received matching direct awards: 38,382 Restricted Stock Units that vest in full one year from the grant date and 10,900 Non‑Qualified Stock Options with a $9.64 exercise price that vest in one year and expire in 2036. After these transactions, indirect Common Stock holdings reported include 65,000 shares held by a trust and 21,000 shares held in an IRA, while the family partnership is shown with 63,283.284 shares. These moves reflect compensation grants and estate or family planning activity rather than open‑market buying or selling.

Positive

  • None.

Negative

  • None.

Insights

Lucier reported equity grants and family gifts, with no market trades.

The filing shows Gregory T. Lucier, a director of DENTSPLY SIRONA, receiving equity compensation while transferring existing interests to a family partnership. He gifted 38,382 Common shares and 10,900 stock options as bona fide gifts, not sales for cash.

Concurrently, he was granted 38,382 RSUs and 10,900 Non‑Qualified Stock Options at an exercise price of $9.64, both vesting in one year. Footnotes note that the family partnership includes a trust for his benefit and that he disclaims beneficial ownership beyond his pecuniary interest. Overall, these are routine compensation and estate‑planning moves with neutral investment signal.

Insider LUCIER GREGORY T
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 10,900 $0.00 --
Gift Stock Option (Right to Buy) 10,900 $0.00 --
Gift Stock Option (Right to Buy) 10,900 $0.00 --
Grant/Award Common Stock 38,382 $0.00 --
Gift Common Stock 38,382 $0.00 --
Gift Common Stock 38,382 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 10,900 shares (Direct, null); Stock Option (Right to Buy) — 10,900 shares (Indirect, By Family Partnership); Common Stock — 38,382 shares (Direct, null); Common Stock — 63,283.284 shares (Indirect, By Family Partnership)
Footnotes (1)
  1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. Stock Options vest in full one (1) year from date of grant. Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs.
Common shares gifted 38,382 shares Bona fide gift to family partnership on 2026-06-03
Stock options gifted 10,900 options Bona fide gift to family partnership, $9.64 exercise price
RSU grant size 38,382 RSUs Restricted Stock Units vesting in full one year from grant
New option grant 10,900 options at $9.64 Non‑Qualified Stock Options vesting in one year, expiring 2036-06-03
Trust holdings 65,000 shares Common Stock held indirectly by a trust after transactions
IRA holdings 21,000 shares Common Stock held indirectly in Gregory Lucier IRA after transactions
Family partnership holdings 63,283.284 shares Common Stock held indirectly by family partnership after gift
Gifted equity total 98,564 shares/options Aggregate shares and option units reported as gifted
Restricted Stock Units (RSUs) financial
"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full..."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Non-Qualified Stock Options (NQSOs) financial
"Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person..."
family partnership financial
"Represents RSUs gifted by the Reporting Person to a family partnership..."
pecuniary interest financial
"The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein..."
Section 16 of the Exchange Act regulatory
"for purposes of Section 16 of the Exchange Act or for any other purpose."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LUCIER GREGORY T

(Last)(First)(Middle)
C/O DENTSPLY SIRONA INC
13320-B BALLANTYNE CORPORATE PLACE

(Street)
CHARLOTTE NORTH CAROLINA 28277

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A38,382(1)A$038,382D
Common Stock06/03/2026G38,382(2)D$00D
Common Stock06/03/2026G38,382(2)A$063,283.284IBy Family Partnership
Common Stock21,000IBy Gregory Lucier IRA
Common Stock65,000IBy a Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$9.6406/03/2026A10,90006/03/2027(3)06/03/2036Common Stock10,900$010,900D
Stock Option (Right to Buy)$9.6406/03/2026G10,900(4)06/03/2027(3)06/03/2036Common Stock10,900$00D
Stock Option (Right to Buy)$9.64(3)06/03/2026G10,900(4)06/05/202606/05/2026Common Stock10,900$010,900IBy Family Partnership
Explanation of Responses:
1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.
2. Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose.
3. Stock Options vest in full one (1) year from date of grant.
4. Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs.
/s/ Jessica Nielsen Causey, Attorney-in-Fact for Gregory T. Lucier06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did XRAY director Gregory Lucier report in this Form 4?

Gregory Lucier reported a combination of equity awards and gifts. He received 38,382 Restricted Stock Units and 10,900 Non‑Qualified Stock Options, and made bona fide gifts of 38,382 Common shares and 10,900 stock options to a related family partnership.

Were any DENTSPLY SIRONA (XRAY) shares bought or sold on the market in this filing?

No open‑market buys or sells are reported. The Form 4 shows equity compensation grants and bona fide gifts of shares and stock options to a family partnership, with transaction prices listed at $0.00, indicating non‑market transfers rather than trading activity.

What are the terms of Gregory Lucier’s new RSU award at DENTSPLY SIRONA (XRAY)?

Lucier received 38,382 Restricted Stock Units that vest in full one year from the grant date. Once vested, restrictions lapse, and the RSUs convert into Common Stock, aligning his compensation with future company performance over that one‑year period.

What are the key details of the Non‑Qualified Stock Options reported for XRAY?

The Non‑Qualified Stock Options cover 10,900 underlying Common shares at a $9.64 exercise price. They vest in full one year from the grant date and have an expiration date in 2036, providing long‑dated equity exposure if vesting conditions are satisfied.

How are Gregory Lucier’s indirect holdings in DENTSPLY SIRONA (XRAY) structured after these transactions?

Post‑transaction entries show 65,000 Common shares held by a trust, 21,000 shares held in an IRA, and 63,283.284 shares held by a family partnership. Footnotes state the partnership includes a trust for his benefit and note limited beneficial ownership claims.

Does the Form 4 for XRAY indicate any pre‑planned trading or 10b5‑1 plan?

The provided data and footnotes describe vesting terms, gifts to a family partnership, and beneficial ownership disclaimers. They do not reference any Rule 10b5‑1 trading plan or pre‑arranged market trading arrangements in connection with these transactions.